{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:20:26Z","timestamp":1763572826612,"version":"3.40.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007689","name":"Universidade de Aveiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007689","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bbr.2025.115541","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T06:36:36Z","timestamp":1742106996000},"page":"115541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Subjective cognitive decline in conjunction with cerebrospinal fluid anti-ATP1A3 autoantibodies and a low amyloid \u03b2 1\u201342\/1\u201340 ratio: Report and literature review"],"prefix":"10.1016","volume":"485","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5785-9594","authenticated-orcid":false,"given":"Niels","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Rentzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Elisa","family":"Sagebiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Hirschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn Hendrik","family":"Schott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Fitzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2025.115541_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4065\/mcp.2010.0326","article-title":"Autoimmune dementia: clinical course and predictors of immunotherapy response","volume":"85","author":"Flanagan","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbr.2025.115541_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00702-021-02316-0","article-title":"Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort","volume":"128","author":"Hansen","year":"2021","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"25","key":"10.1016\/j.bbr.2025.115541_bib3","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023333118","article-title":"Early role for a Na+,K+-ATPase (ATP1A3) in brain development","volume":"118","author":"Smith","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbr.2025.115541_bib4","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/tra.12332","article-title":"Identification of a VxP targeting signal in the flagellar Na+\/K+-ATPase","volume":"16","author":"Laird","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.bbr.2025.115541_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/srep31972","article-title":"Cognitive deficits caused by a disease-mutation in the \u03b13 Na(+)\/K(+)-ATPase isoform","volume":"6","author":"Holm","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2025.115541_bib6","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.neuint.2012.07.006","article-title":"Hippocampal levels and activity of the sodium\/potassium transporting ATPase subunit \u03b1-3 (AT1A3) are paralleling memory training in the multiple T-maze in the C57BL\/6J mouse","volume":"61","author":"Heo","year":"2012","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.bbr.2025.115541_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10571-018-0641-2","article-title":"ATP synthase subunit beta immunostaining is reduced in the sclerotic hippocampus of epilepsy patients","volume":"39","author":"Mota","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2025.115541_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105012","article-title":"Comparative analysis of alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism ATP1A3 mutations reveals functional deficits, which do not correlate with disease severity","volume":"143","author":"Lazarov","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2025.115541_bib9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.neuint.2012.07.006","article-title":"Hippocampal levels and activity of the sodium\/potassium transporting ATPase subunit \u03b1-3 (AT1A3) are paralleling memory training in the multiple T-maze in the C57BL\/6J mouse","volume":"61","author":"Heo","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2025.115541_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2025.115460","article-title":"Update on autoimmune dementia and its precursors","volume":"482","author":"Hansen","year":"2025","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2025.115541_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837376","article-title":"Cerebrospinal fluid total tau protein correlates with longitudinal, progressing cognitive dysfunction in anti-neural autoantibody-associated dementia and Alzheimer's dementia: a case-control study","volume":"13","author":"Hansen","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.bbr.2025.115541_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.879009","article-title":"Case report: Alzheimer's dementia associated with cerebrospinal fluid neurochondrin autoantibodies","volume":"13","author":"Hansen","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbr.2025.115541_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1412813","article-title":"Brain-targeting autoantibodies in patients with dementia","volume":"15","author":"Staabs","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbr.2025.115541_bib14","article-title":"Natural anti-NMDAR1 autoantibodies associate with slowed decline of cognitive functions in Alzheimer's diseases","author":"Zhou","year":"2025","journal-title":"medRxiv [Preprint]"},{"key":"10.1016\/j.bbr.2025.115541_bib15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"Subjective cognitive decline initiative (SCD-I) working group. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bbr.2025.115541_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1474-4422(19)30368-0","article-title":"The characterisation of subjective cognitive decline","volume":"19","author":"Jessen","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbr.2025.115541_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep31972","article-title":"Cognitive deficits caused by a disease-mutation in the \u03b13 Na(+)\/K(+)-ATPase isoform","volume":"6","author":"Holm","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2025.115541_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3233\/JAD-140276","article-title":"Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates","volume":"42","author":"Bondi","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2025.115541_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-140771","article-title":"Amyloid-\u03b2 42\/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays","volume":"43","author":"Lewczuk","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.bbr.2025.115541_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"Contributors. NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bbr.2025.115541_bib21","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.bbr.2025.115541_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13195-015-0159-5","article-title":"Diagnostic value of cerebrospinal fluid A\u03b2 ratios in preclinical Alzheimer's disease","volume":"7","author":"Adamczuk","year":"2015","journal-title":"Alzheimers Res. Ther."},{"issue":"6","key":"10.1016\/j.bbr.2025.115541_bib23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1037\/bne0000097","article-title":"Characterization of cognitive deficits in mice with an alternating hemiplegia-linked mutation","volume":"129","author":"Kirshenbaum","year":"2015","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.bbr.2025.115541_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi3647","article-title":"ATP1A3 as a target for isolating neuron-specific extracellular vesicles from human brain and biofluids","volume":"9","author":"You","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbr.2025.115541_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-190771","article-title":"Amyloid-\u03b2 and synaptic vesicle dynamics: a cacophonic orchestra","volume":"72","author":"Fagiani","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2025.115541_bib26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jalz.2018.01.011","article-title":"Synaptic vesicle cycle and amyloid \u03b2: Biting the hand that feeds","volume":"14","author":"Ovsepian","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bbr.2025.115541_bib27","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1212\/WNL.0b013e3182698d6c","article-title":"Psychiatric disorders in rapid-onset dystonia-parkinsonism","volume":"79","author":"Brashear","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2025.115541_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2023.104629","article-title":"Predictors of progression from subjective cognitive decline to objective cognitive impairment: a systematic review and meta-analysis of longitudinal studies","volume":"149","author":"An","year":"2024","journal-title":"Int J. Nurs. Stud."},{"key":"10.1016\/j.bbr.2025.115541_bib29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2020.03.011","article-title":"INSIGHT-preAD study group and for the Alzheimer\u015b Disease Neuroimaging Initiative. In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's disease","volume":"93","author":"Teipel","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2025.115541_bib30","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41380-020-0672-1","article-title":"Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury","volume":"26","author":"Pan","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2025.115541_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ana.24545","article-title":"The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1","volume":"79","author":"Castillo-Gomez","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbr.2025.115541_bib32","article-title":"Autoantibodies against NMDAR subunit NR1 disappear from blood upon anesthesia","volume":"24","author":"Teller","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.bbr.2025.115541_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000001493","article-title":"Neuronal Na+\/K+ ATPase is an autoantibody target in paraneoplastic neurologic syndrome","volume":"84","author":"Scharf","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2025.115541_bib34","series-title":"GeneReviews\u00ae","first-page":"1993","article-title":"ATP1A3-Related Neurologic Disorders","author":"Brashear","year":"2008"},{"key":"10.1016\/j.bbr.2025.115541_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.17712\/nsj.2023.3.20220131","article-title":"Expanding the Allelic spectrum in ATP1A3-related disorders with 3 novel mutations and clinic features","volume":"28","author":"Alyamani","year":"2023","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.bbr.2025.115541_bib36","doi-asserted-by":"crossref","first-page":"e1511","DOI":"10.1212\/WNL.0000000000200927","article-title":"The phenotypic continuum of ATP1A3-related disorders","volume":"99","author":"Vezyroglou","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2025.115541_bib37","doi-asserted-by":"crossref","first-page":"fcab232","DOI":"10.1093\/braincomms\/fcab232","article-title":"Multi-model mapping of phonemic fluency","volume":"3","author":"Cipolotti","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.bbr.2025.115541_bib38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jamaneurol.2021.5216","article-title":"Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum","volume":"79","author":"Jansen","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbr.2025.115541_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-022-01118-0","article-title":"DELCODE study group. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study","volume":"15","author":"Brosseron","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbr.2025.115541_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-019-1399-2","article-title":"Glial activation and inflammation along the Alzheimer's disease continuum","volume":"16","author":"Nordengen","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbr.2025.115541_bib41","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jalz.2019.01.015","article-title":"Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study","volume":"15","author":"Lle\u00f3","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bbr.2025.115541_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/antib12040081","article-title":"Role of specific autoantibodies in neurodegenerative diseases: pathogenic antibodies or promising biomarkers for diagnosis","volume":"12","author":"Miteva","year":"2023","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.bbr.2025.115541_bib43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbi.2023.11.018","article-title":"Specific serum autoantibodies predict the development and progression of Alzheimer's disease with high accuracy","volume":"115","author":"Fang","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2025.115541_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-022-01143-z","article-title":"FACEHBI study group. Clinical performance of an antibody-free assay for plasma A\u03b242\/A\u03b240 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline","volume":"15","author":"Pascual-Lucas","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbr.2025.115541_bib45","article-title":"Amyloid and SCD jointly predict cognitive decline across Chinese and German cohorts","author":"Shao","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bbr.2025.115541_bib46","doi-asserted-by":"crossref","first-page":"e1866","DOI":"10.1212\/WNL.0000000000201072","article-title":"Progression of subjective cognitive decline to MCI or dementia in relation to biomarkers for Alzheimer disease: a meta-analysis","volume":"99","author":"Rostamzadeh","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2025.115541_bib47","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3233\/JAD-160407","article-title":"AgeCoDe Study Group. Differential risk of incident Alzheimer's disease dementia in stable versus unstable patterns of subjective cognitive decline","volume":"54","author":"Wolfsgruber","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2025.115541_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2021.07.003","article-title":"Anti-NR2 glutamate receptor antibodies as an early biomarker of cerebral small vessel disease","volume":"96","author":"Dobrynina","year":"2021","journal-title":"Clin. Biochem."},{"issue":"9","key":"10.1016\/j.bbr.2025.115541_bib49","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jamaoncol.2021.2049","article-title":"Association between neuronal autoantibodies and cognitive impairment in patients with lung cancer","volume":"7","author":"Bartels","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbr.2025.115541_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1256745","article-title":"Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementia","volume":"14","author":"Ehtewish","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbr.2025.115541_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106843","article-title":"Long-term exposure to anti-GluA3 antibodies triggers functional and structural changes in hippocampal neurons","volume":"207","author":"Italia","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2025.115541_bib52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bbi.2024.03.018","article-title":"Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features","volume":"118","author":"Italia","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2025.115541_bib53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-024-02805-y","article-title":"Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy","volume":"148","author":"Gelpi","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2025.115541_bib54","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/alz.12785","article-title":"Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia","volume":"19","author":"Kleineidam","year":"2023","journal-title":"Alzheimers Dement"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:10:30Z","timestamp":1745989830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432825001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":54,"alternative-id":["S0166432825001275"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115541","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subjective cognitive decline in conjunction with cerebrospinal fluid anti-ATP1A3 autoantibodies and a low amyloid \u03b2 1\u201342\/1\u201340 ratio: Report and literature review","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115541"}}